These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 36775190
1. Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network. Narayan HK, Lizcano A, Lam-Hine T, Ulloa-Gutierrez R, Bainto EV, Garrido-García LM, Estripeaut D, Del Aguila O, Gómez V, Faugier-Fuentes E, Miño-León G, Beltrán S, Cofré F, Chacon-Cruz E, Saltigeral-Simental P, Martínez-Medina L, Dueñas L, Luciani K, Rodríguez-Quiroz FJ, Camacho Moreno G, Viviani T, Alvarez-Olmos MI, Marques HHS, López-Medina E, Pirez MC, Tremoulet AH, Kawasaki Disease REKAMLATINA Network Study Group. J Pediatr; 2023 Dec; 263():113346. PubMed ID: 36775190 [Abstract] [Full Text] [Related]
2. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW. J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390 [Abstract] [Full Text] [Related]
3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms. Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V. Turk J Pediatr; 2019 Sep 15; 61(5):648-656. PubMed ID: 32104995 [Abstract] [Full Text] [Related]
4. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events. Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K, The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K. JAMA Pediatr; 2018 May 07; 172(5):e180030. PubMed ID: 29507955 [Abstract] [Full Text] [Related]
5. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE. Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M. J Pediatr; 2022 Jan 07; 240():158-163.e4. PubMed ID: 34461064 [Abstract] [Full Text] [Related]
6. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement. Koyama Y, Miura M, Kobayashi T, Hokosaki T, Suganuma E, Numano F, Furuno K, Shiono J, Ebata R, Fuse S, Fukazawa R, Mitani Y. Eur J Pediatr; 2023 Feb 07; 182(2):633-640. PubMed ID: 36434403 [Abstract] [Full Text] [Related]
7. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study. Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y. Cardiology; 2023 Feb 07; 148(5):457-468. PubMed ID: 37231847 [Abstract] [Full Text] [Related]
8. The Harada score in the US population of children with Kawasaki disease. Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J. Hosp Pediatr; 2014 Jul 07; 4(4):233-8. PubMed ID: 24986993 [Abstract] [Full Text] [Related]
9. [Kawasaki disease in children--9 years experience]. Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A. Med Wieku Rozwoj; 2005 Jul 07; 9(2):179-93. PubMed ID: 16085959 [Abstract] [Full Text] [Related]
10. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P. Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139 [Abstract] [Full Text] [Related]
11. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis. Miyata K, Bainto EV, Sun X, Jain S, Dummer KB, Burns JC, Tremoulet AH. Arch Dis Child; 2023 Oct 26; 108(10):833-838. PubMed ID: 37258054 [Abstract] [Full Text] [Related]
12. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG. Pediatrics; 2019 Jun 26; 143(6):. PubMed ID: 31048414 [Abstract] [Full Text] [Related]
13. [Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease]. Liu WQ, Xia B, Fan W, Yu Z, Lin WL, Chen L, Wang C, Liu BN, Li J, Yang J. Zhonghua Er Ke Za Zhi; 2022 Jun 02; 60(6):588-593. PubMed ID: 35658368 [Abstract] [Full Text] [Related]
14. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China. Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H. Clin Rheumatol; 2018 Jul 02; 37(7):1945-1951. PubMed ID: 29330741 [Abstract] [Full Text] [Related]
15. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease. Fabi M, Andreozzi L, Frabboni I, Dormi A, Corinaldesi E, Lami F, Cicero C, Tchana B, Francavilla R, Sprocati M, Bigucci B, Balsamo C, Valin PS, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M. Clin Rheumatol; 2021 Apr 02; 40(4):1507-1514. PubMed ID: 32936425 [Abstract] [Full Text] [Related]
16. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease. Haiyan G, Jianming L, Suqian T, Dong Q, Shuang L, Jin Z. BMC Pediatr; 2022 Jan 07; 22(1):29. PubMed ID: 34996405 [Abstract] [Full Text] [Related]
17. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk. Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M. Pediatr Infect Dis J; 2023 Jul 01; 42(7):608-613. PubMed ID: 37053581 [Abstract] [Full Text] [Related]
18. A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm. Peng Y, Cheng Z, Yi Q. Clin Exp Med; 2023 Aug 01; 23(4):1317-1324. PubMed ID: 36151486 [Abstract] [Full Text] [Related]
19. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country. Mat Bah MN, Alias EY, Razak H, Sapian MH, Foo FH, Abdullah N. Eur J Pediatr; 2021 Aug 01; 180(8):2599-2606. PubMed ID: 34086103 [Abstract] [Full Text] [Related]
20. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin. Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S. J Pediatr; 2020 Dec 01; 227():224-230.e3. PubMed ID: 32810506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]